Trial Profile
Comparison of efficacy and safety of exenatide extended-release and dulaglutide in type 2 diabetes mellitus patients who are insufficiently controlled with oral antidiabetic agents
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2017
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Sep 2015 New trial record